RHHVF
Price
$393.87
Change
+$31.99 (+8.84%)
Updated
Nov 18 closing price
Capitalization
310.28B
70 days until earnings call
Intraday BUY SELL Signals
SCLX
Price
$17.06
Change
+$0.69 (+4.22%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
130.32M
Intraday BUY SELL Signals
Interact to see
Advertisement

RHHVF vs SCLX

Header iconRHHVF vs SCLX Comparison
Open Charts RHHVF vs SCLXBanner chart's image
Roche Holding
Price$393.87
Change+$31.99 (+8.84%)
Volume$29.95K
Capitalization310.28B
Scilex Holding
Price$17.06
Change+$0.69 (+4.22%)
Volume$6.03K
Capitalization130.32M
RHHVF vs SCLX Comparison Chart in %
RHHVF
Daily Signal:
Gain/Loss:
SCLX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RHHVF vs. SCLX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a Hold and SCLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (RHHVF: $383.00 vs. SCLX: $17.18)
Brand notoriety: RHHVF and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 29% vs. SCLX: 44%
Market capitalization -- RHHVF: $310.28B vs. SCLX: $130.32M
RHHVF [@Pharmaceuticals: Major] is valued at $310.28B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $130.32M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $939.41B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $99.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 2 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • RHHVF’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 5 TA indicator(s) are bullish while SCLX’s TA Score has 4 bullish TA indicator(s).

  • RHHVF’s TA Score: 5 bullish, 5 bearish.
  • SCLX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than RHHVF.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а +5.80% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -9.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.05%. For the same industry, the average monthly price growth was +0.88%, and the average quarterly price growth was +16.69%.

Reported Earning Dates

RHHVF is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-0.05% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($310B) has a higher market cap than SCLX($130M). RHHVF YTD gains are higher at: 36.786 vs. SCLX (15.117). RHHVF has higher annual earnings (EBITDA): 18B vs. SCLX (-70.91M). RHHVF has more cash in the bank: 12B vs. SCLX (4.1M). SCLX has less debt than RHHVF: SCLX (41.8M) vs RHHVF (33B). RHHVF has higher revenues than SCLX: RHHVF (63.5B) vs SCLX (44.2M).
RHHVFSCLXRHHVF / SCLX
Capitalization310B130M238,462%
EBITDA18B-70.91M-25,384%
Gain YTD36.78615.117243%
P/E Ratio25.98N/A-
Revenue63.5B44.2M143,665%
Total Cash12B4.1M292,754%
Total Debt33B41.8M78,947%
FUNDAMENTALS RATINGS
RHHVF: Fundamental Ratings
RHHVF
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RHHVFSCLX
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 8 days ago
73%
Declines
ODDS (%)
Bearish Trend 17 days ago
55%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
RHHVF
Daily Signal:
Gain/Loss:
SCLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRM19.900.57
+2.94%
Vroom Inc
OCUL12.090.33
+2.81%
Ocular Therapeutix
NCNA3.360.05
+1.51%
NuCana plc
IT225.89-0.43
-0.19%
Gartner
LXRX1.45-0.02
-1.36%
Lexicon Pharmaceuticals

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-2.76%
RHHBY - RHHVF
65%
Loosely correlated
-0.68%
JNJ - RHHVF
31%
Poorly correlated
+1.25%
NVS - RHHVF
27%
Poorly correlated
-0.55%
AZN - RHHVF
26%
Poorly correlated
-0.63%
RHHBF - RHHVF
25%
Poorly correlated
N/A
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+4.95%
BIIB - SCLX
20%
Poorly correlated
-0.53%
AMRN - SCLX
20%
Poorly correlated
+1.08%
SNY - SCLX
9%
Poorly correlated
-2.18%
ABBV - SCLX
8%
Poorly correlated
-0.41%
RHHVF - SCLX
8%
Poorly correlated
-2.76%
More